Russell Frank Company’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Russell Frank Company’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.47M	Sell	60,996 -10,405	-15%	-$660K	﹤0.01%	1740
2015 Q4	$6.37M	Buy	71,401 +19,938	+39%	+$1.57M	0.01%	1145
2015 Q3	$3.81M	Buy	51,463 +216	+0.4%	+$18K	0.01%	1440
2015 Q2	$4.14M	Buy	51,247 +6,046	+13%	+$394K	0.01%	1530
2015 Q1	$1.89M	Buy	+45,201	New	+$1.28M	﹤0.01%	1808

Other funds holding EGRX

PAI

ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Russell Frank Company's EGRX Position: Q1 2016 in Review

Russell Frank Company reduced its Eagle Pharmaceuticals, Inc. (EGRX) stake by 15% in Q1 2016, selling an estimated $660K and leaving 60,996 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

Russell Frank Company first reported a position in EGRX in Q1 2015 and has held it in 5 quarters since. The position peaked at $6.37M in Q4 2015. 119 funds tracked by Wall St. Rank hold EGRX as of Q1 2016.

Russell Frank Company held 60,996 shares of Eagle Pharmaceuticals, Inc. worth $2.47M as of Q1 2016.
Russell Frank Company sold 10,405 Eagle Pharmaceuticals, Inc. shares in Q1 2016, an estimated $660K.
Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1740 holding.
Russell Frank Company first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2015 and has held it in 5 quarters since.
Russell Frank Company's Eagle Pharmaceuticals, Inc. position peaked at $6.37M in Q4 2015.
119 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.